Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study

NCT06177704 is registered in ClinicalTrials.gov with Institut universitaire de cardiologie et de pneumologie de Québec, University Laval as lead sponsor.

NCT NCT06177704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06177704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study
Lead sponsor
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
January 1, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

device-related thrombus (drt), major bleeding - timi classification, major cardioembolic events, percutaneous left atrial appendage occlusion (laao), thromboembolic event